News
Business Insider's July 30 virtual event features executives talking about procurement innovation strategies. The panel ...
Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...
As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...
Risks to BMY include potential for tariffs to raise costs of drugs manufactured outside of the U.S. Moreover, drug pricing ...
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The MachineCon GCC Summit 2025 celebrated industry leaders with the GCC Excellence Awards, recognising exceptional ...
Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective non-hormonal contraception during treatment with AUGTYRO and for 2 months following ...
Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
TIGIT-targeting therapies have largely disappointed in recent months, with failed studies, terminated partnerships and ...
Bristol-Myers Squibb is testing MORAb-202 in a Phase 2 trial to challenge traditional chemotherapy for platinum-resistant ...
LONDON, GREATER LONDON, UNITED KINGDOM, July 4, 2025 /EINPresswire.com/ -- The anti-inflammatory drugs market size has grown rapidly in recent years. From $136.86 billion in 2024, it is predicted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results